The Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple Sclerosis

Table 4

Analysis of symptom improvement in cases with MS.

	MS cases ()	MS/cannabis ()	value
Pain	62 (50.8%)	19 (67.9%)	0.019^b
Limb spasm	73 (59.8%)	22 (78.6%)	0.011^b
Fatigue	29 (23.77%)	10 (35.7%)	0.045^b
Walking difficulties	69 (56.6%)	18 (64.3%)	0.043^b
Sexual dysfunction	64 (52.5%)	14 (50%)	0.638^b
Anxiety	53 (43.4%)	18 (64.3%)	0.001^b
Altered mood	49 (40.2%)	7 (25%)	0.025^b
Visual disturbances	58 (47.5%)	13 (46.4%)	0.876^b
Bladder symptoms	60 (49.18%)	14 (50%)	0.956^b

^bChi-squared test.